Raphael J. Mannino - 03 Sep 2021 Form 4 Insider Report for Matinas BioPharma Holdings, Inc. (MTNB)

Role
Chief Scientific Officer
Signature
/s/ Keith A. Kucinski, attorney in fact for Raphael J. Mannino
Issuer symbol
MTNB
Transactions as of
03 Sep 2021
Net transactions value
$0
Form type
4
Filing time
14 Sep 2021, 17:30:10 UTC
Previous filing
24 Jun 2021
Next filing
15 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MTNB Common Stock, par value $0.0001 per share Other $0 +462,150 +32% $0.000000 1,919,715 03 Sep 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares received pursuant to an amendment to the Agreement and Plan of Merger dated as of January 29, 2015 by an among the Issuer, Saffron Merger Sub, Inc. and Aquarius Biotechnologies Inc.